C

에스디바이오센서

137310KOSPI의료용 기기 제조업

50.3 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40
News Sentiment21.3 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Declined 12.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SD Biosensor, established in 2010, specializes in in-vitro diagnostics, offering products such as STANDARD Q, STANDARD F, and STANDARD E, which are known for high sensitivity and specificity. These products are used for rapid testing of various diseases, including COVID-19, and hold significant market share globally. The in-vitro diagnostics industry plays a crucial role in disease prevention and public health, with stringent regulations in major countries.

Number of Employees

656people

Average Salary

67.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 21.514.0Point
PBR
0.37Industry Average 1.387.0Point

Half of industry avg (excellent)

ROE
-19.49Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
18.81Industry Average 11.650.5Point

1.6x industry avg (risky)

Trend 2023~20253.5 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲4.1% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲14.2% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -13.0% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 7,080Won52-week high 11,80052-week low 7,080
1-month return1.0Point

1m -12.05% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral기업지배구조보고서공시2026-05-29
  • Neutral분기보고서 (2026.03)2026-05-14